When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NTGN - Neon up 13% premarket on neoantigen cancer vaccine data
Neon Therapeutics Inc.
Thinly traded micro cap Neon Therapeutics (NASDAQ:NTGN) is up 13% premarket on modestly higher volume in reaction to positive topline results from a Phase 1b clinical trial, NT-001, evaluating NEO-PV-01, its personal neoantigen vaccine candidate, combined with Bristol-Myers Squibb's Opdivo (nivolumab), in patients with advanced/metastatic melanoma, smoking-associated non-small lung cancer (NSCLC) or bladder cancer.
More news on: Neon Therapeutics, Inc., Healthcare stocks news, Stocks on the move,